Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 56 Biliary Tract Neoplasms 24 Cholangiocarcinoma 23 Nasopharyngeal Carcinoma 22 Carcinoma, Non-Small-Cell Lung 22 Urinary Bladder Neoplasms 18 Breast Neoplasms 18 Neoplasm Metastasis 17 Lung Neoplasms 14 Lymphoma, Large B-Cell, Diffuse 13 Colorectal Neoplasms 12 Carcinoma, Transitional Cell 12 Recurrence 9 Non-Muscle Invasive Bladder Neoplasms 9 Sarcoma 8 Ovarian Neoplasms 8 Triple Negative Breast Neoplasms 7 Neoplasms 7 Gallbladder Neoplasms 7 Hodgkin Disease 6 Nasopharyngeal Neoplasms 5 Bile Duct Neoplasms 5 Adenocarcinoma 5 Uterine Cervical Neoplasms 4 Locally Advanced Pancreatic Cancer 4 Endometrial Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Pancreatic Adenocarcinoma 3 Osteosarcoma 3 Lymphoma, T-Cell, Peripheral 3

Interventions

Drug Therapy 4 Pemetrexed 3 Carboplatin 3 osimertinib 2 Radiotherapy 2 toripalimab 1 tislelizumab 1 sugemalimab 1 spartalizumab 1 sintilimab 1 pembrolizumab 1 cemiplimab 1 aflutinib 1 Vinorelbine 1 Radiosurgery 1 Platinum 1 Paclitaxel 1 Gemcitabine 1 Docetaxel 1 Cisplatin 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NSCLC × Gemcitabine × Clear all

NCT06576635 2026-01-20

LUNG-05

University of Illinois at Chicago

Phase NA Recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡